Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2009
Date:11/6/2009

33 Loss on sale of property, plant and equipment 65 - 65 - Impairment loss on long-term investment - 400 - 1,091 Non-cash financial expenses 206 101 496 288 Unrealized foreign exchange loss (gain) (1,177) 647 (2,012) 386 Stock-based compensation 136 410 1,339 1,981 ------------------------------------------------------------------------- (7,196) (3,952) (18,416) (20,758) Net change in non-cash items 1,502 (6,623) (834) (5,906) ------------------------------------------------------------------------- (5,694) (10,575) (19,250) (26,664) ------------------------------------------------------------------------- INVESTING ACTIVITIES Acquisition of marketable securities - (16,962) (8,466) (40,515) Proceeds from maturities of marketable securities 595 - 23,605 - Proceeds from disposals of marketable securities 3,400 11,200 9,420 67,019 Acquisition of restricted long-term investment - - - (45) Acquisition of property, plant and equipment (251) (196) (319) (1,344) Acquisition of intangible assets (4) (57) (57) (96) ------------------------------------------------------------------------- 3,740 (6,015) 24,183 25,019 ------------------------------------------------------------------------- FINANCING ACTIVITIES Repaym
'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
2. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
3. Labopharm submits response to FDA for novel antidepressant
4. Labopharm Reports Results for Second Quarter Fiscal 2009
5. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
6. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
7. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
8. Labopharm amends debt facility agreement with Hercules
9. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
10. Labopharm Reports Results for First Quarter Fiscal 2009
11. Labopharm announces details for first quarter results conference call and annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... near green spaces deliver babies with significantly higher ... Spaces and Adverse Pregnancy Outcomes" published in the ... A team of researchers from Israel and Spain, ... nearly 40,000 single live births from a registry ... the impact of green surroundings during pregnancy and ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Drorit Silverman, ... unveiled new plans to raise investment capital through her ... fitness concept in the United States. , According to ... of 24/7 fitness centers provide a great window of ... rapidly expanding space. In addition to this, Silverman looks ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Qualis ... and care management organizations, has published a complimentary, ... approach to engaging patients and families in infection ... at multiple hospitals, the toolkit provides a step-by-step ... with patients and their families early in a ...
(Date:7/28/2014)... (HealthDay News) -- A common inflammatory muscle disorder ... may increase the risk for heart attack and ... study found that patients with polymyalgia rheumatica are ... that affect the blood vessels. Doctors should carefully ... polymyalgia rheumatica to reduce their risk for complications, ...
(Date:7/28/2014)... (SMU) Smart phones and mobile devices are on ... health ("mHealth") apps capable of providing everything from cardiac ... broaden access to medical treatment and control costs, several ... England Journal of Medicine (NEJM) report that more ... Administration (FDA) to ensure consumer confidence and safety. Out ...
Breaking Medicine News(10 mins):Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Patient Engagement in Hospital Infection Control: Online Toolkit Provides a New Solution 2Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2
... Corresponding Journal of Nutrition supplement urges health professionals to ... to be published in the June issue of the ... and the general public to stop demonizing high fructose ... rethink the myths about high fructose corn syrup,s impact ...
... NAS to Store Public Database of Genomic and Trait Data ... Isilon(R) Systems (Nasdaq: ISLN ), the ... Personal Genome Project (PGP) has deployed Isilon ... for an unprecedented research project aimed at transforming the use ...
... Keeping Up on Developments in the Long term Care Insurance ... interest in long term care insurance need no longer dig ... pros do: have the information come to them, in bits ... secrets," says Jonas Roeser, Senior Vice President of Marketing & ...
... on lung cancer and mesothelioma specialists into one of ... asbestos-related diseases. Our searchable, easy-to-use database contains doctor profiles ... it easy for residents of California or New York, ... in their area. , ...
... medical malpractice challenge by introducing low tech solution ... introduces standardized shift reporting and note taking to ... to day tasks.RNReport Card is more efficient by ... It fits conveniently in the pocket of your ...
... Packard Children,s Hospital and the Stanford University School of ... deadly and mysterious bowel disease that strikes medically fragile ... understanding of the disease and its medical management, and ... major killer of children and young adults. , The ...
Cached Medicine News:Health News:Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop 2Health News:Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop 3Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 2Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 3Health News:Long Term Care Alerting Methods Revealed by Industry Leaders 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 3Health News:RN Sisters Bring Low-Tech Innovations to New Nurses and Nursing Students 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 3
(Date:7/28/2014)... -- UBM Medica US announces that Diagnostic Imaging ... professionals, explored the complex situation regarding measuring the ... The shift from fee-for-service has left radiology at a ... determined in the new payment model . ... who recognized the complexity of the radiologist,s value: ...
(Date:7/28/2014)... July 28, 2014  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Tuesday, August ... and Michael Carruthers , Chief Financial ... August 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) ...
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
Breaking Medicine Technology:Diagnostic Imaging Delves into Measuring the Radiologist's Value 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
... TOULOUSE, France, May 15 Cerenis,Therapeutics SA ... compounds for the treatment of cardiovascular and,metabolic ... a Phase I,clinical trial for CER-002, one ... a peroxisome proliferator-activated receptor (PPAR),delta-specific agonist in ...
... Therapy that, Combined, with Aspirin, Causes Less Bleeding ... and Aspirin, According to a New Report ... Decision Resources, one of the,world,s leading research ... that Daiichi Sankyo/Eli Lilly,s Effient offers,improvement in patient ...
Cached Medicine Technology:Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3
... Finn Revision Knee System ... distal femoral replacement options. The ... Finn Rotating Hinge Knee, promotes ... function and is designed for ...
The Advance stemmed medial-pivot knee is a revision knee that provides unique and competitive features....
... The NexGen Legacy LCCK Femoral Component ... additional prosthetic stabilization due to inadequate ... and require augmentation and/or stem extensions ... NexGen LCCK is available with a ...
The Duracon system provides superb articular conformity throughout the range of motion, reducing contact stresses generally associated with wear....
Medicine Products: